ADAR1 Capital Management, LLC (CIK 1940272) reported 25 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-05-21). Recent activity: Buy INM (68,551 shares), Buy INM (200,000 shares), Buy INM (200,000 shares), Buy RLYB (6,009 shares), Buy RLYB (10,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-21 | InMed Pharmaceuticals Inc. (INM) | Insider | Buy | 68,551 | $109,668 |
| 2026-05-21 | InMed Pharmaceuticals Inc. (INM) | Insider | Buy | 200,000 | $312,080 |
| 2026-05-21 | InMed Pharmaceuticals Inc. (INM) | Insider | Buy | 200,000 | $299,800 |
| 2026-05-20 | Rallybio Corp (RLYB) | Insider | Buy | 6,009 | $83,981 |
| 2026-05-20 | Rallybio Corp (RLYB) | Insider | Buy | 10,000 | $139,822 |
| 2026-05-20 | Rallybio Corp (RLYB) | Insider | Buy | 200 | $2,760 |
| 2026-05-15 | Rallybio Corp (RLYB) | Insider | Buy | 4,081 | $56,315 |
| 2026-05-15 | Rallybio Corp (RLYB) | Insider | Buy | 75,178 | $1.1M |
| 2026-05-15 | Rallybio Corp (RLYB) | Insider | Buy | 100 | $1,380 |
| 2026-05-15 | Rallybio Corp (RLYB) | Insider | Buy | 200 | $2,790 |
| 2026-05-13 | Rallybio Corp (RLYB) | Insider | Buy | 19,900 | $278,600 |
| 2026-05-13 | Rallybio Corp (RLYB) | Insider | Buy | 25,000 | $350,000 |
| 2026-05-13 | Rallybio Corp (RLYB) | Insider | Buy | 5,100 | $71,392 |
| 2026-05-13 | Rallybio Corp (RLYB) | Insider | Buy | 800 | $11,063 |
| 2025-10-15 | Keros Therapeutics, Inc. (KROS) | Insider | Sell | 4.4M | $77.9M |
| 2025-10-15 | Keros Therapeutics, Inc. (KROS) | Insider | Sell | 254,669 | $4.5M |
| 2025-10-15 | Keros Therapeutics, Inc. (KROS) | Insider | Sell | 743,358 | $13.2M |
| 2025-06-24 | Keros Therapeutics, Inc. (KROS) | Insider | Sell | 100 | $6,000 |
| 2025-06-24 | Keros Therapeutics, Inc. (KROS) | Insider | Sell | 1,400 | $0 |
| 2025-06-24 | Keros Therapeutics, Inc. (KROS) | Insider | Sell | 200 | $0 |
| 2025-04-11 | Keros Therapeutics, Inc. (KROS) | Insider | Buy | 18,560 | $174,464 |
| 2025-04-11 | Keros Therapeutics, Inc. (KROS) | Insider | Buy | 16,365 | $153,831 |
| 2025-04-11 | Keros Therapeutics, Inc. (KROS) | Insider | Buy | 325,000 | $3.2M |
| 2025-04-11 | Keros Therapeutics, Inc. (KROS) | Insider | Buy | 500,000 | $5.2M |
| 2025-04-11 | Keros Therapeutics, Inc. (KROS) | Insider | Buy | 74,333 | $767,860 |
Source: SEC Form 4 filings · as of 2026-05-21